BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27567537)

  • 21. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
    Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE
    Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells.
    Wortel IMN; van der Meer LT; Kilberg MS; van Leeuwen FN
    Trends Endocrinol Metab; 2017 Nov; 28(11):794-806. PubMed ID: 28797581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the synthesis of ribosomal RNA take place within nucleolar fibrillar centers or dense fibrillar components? A critical appraisal.
    Raska I; Dundr M; Koberna K; Melcák I; Risueño MC; Török I
    J Struct Biol; 1995; 114(1):1-22. PubMed ID: 7772414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
    Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S
    J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
    Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
    Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anacardic acid induces cell apoptosis associated with induction of ATF4-dependent endoplasmic reticulum stress.
    Huang H; Hua X; Liu N; Li X; Liu S; Chen X; Zhao C; Lan X; Yang C; Dou QP; Liu J
    Toxicol Lett; 2014 Aug; 228(3):170-8. PubMed ID: 24853302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
    Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
    Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway.
    Ludwig MP; Galbraith MD; Eduthan NP; Hill AA; Clay MR; Tellez CM; Wilky BA; Elias A; Espinosa JM; Sullivan KD
    Cancer Res; 2023 Aug; 83(15):2543-2556. PubMed ID: 37205634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells.
    Nawrocki ST; Carew JS; Dunner K; Boise LH; Chiao PJ; Huang P; Abbruzzese JL; McConkey DJ
    Cancer Res; 2005 Dec; 65(24):11510-9. PubMed ID: 16357160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.
    Tagoug I; Jordheim LP; Herveau S; Matera EL; Huber AL; Chettab K; Manié S; Dumontet C
    Clin Cancer Res; 2013 Jul; 19(13):3556-66. PubMed ID: 23674497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The novel β2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.
    Kraus M; Bader J; Geurink PP; Weyburne ES; Mirabella AC; Silzle T; Shabaneh TB; van der Linden WA; de Bruin G; Haile SR; van Rooden E; Appenzeller C; Li N; Kisselev AF; Overkleeft H; Driessen C
    Haematologica; 2015 Oct; 100(10):1350-60. PubMed ID: 26069288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis.
    Intine RV; Dundr M; Vassilev A; Schwartz E; Zhao Y; Zhao Y; Depamphilis ML; Maraia RJ
    Mol Cell Biol; 2004 Dec; 24(24):10894-904. PubMed ID: 15572691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma antigen-D2: A nucleolar protein undergoing delocalization during cell cycle and after cellular stress.
    Pirlot C; Thiry M; Trussart C; Di Valentin E; Piette J; Habraken Y
    Biochim Biophys Acta; 2016 Apr; 1863(4):581-95. PubMed ID: 26705694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT1 suppresses activating transcription factor 4 (ATF4) expression in response to proteasome inhibition.
    Woo SR; Park JE; Kim YH; Ju YJ; Shin HJ; Joo HY; Park ER; Hong SH; Park GH; Lee KH
    J Microbiol Biotechnol; 2013 Dec; 23(12):1785-90. PubMed ID: 24100623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma.
    Wang J; Jiang J; Chen H; Wang L; Guo H; Yang L; Xiao D; Qing G; Liu H
    Oncogene; 2019 Oct; 38(41):6737-6751. PubMed ID: 31406244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of TopBP1 induce ATR-dependent shut-down of rRNA transcription and nucleolar segregation.
    Sokka M; Rilla K; Miinalainen I; Pospiech H; Syväoja JE
    Nucleic Acids Res; 2015 May; 43(10):4975-89. PubMed ID: 25916852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar stress induces ubiquitination-independent proteasomal degradation of PICT1 protein.
    Maehama T; Kawahara K; Nishio M; Suzuki A; Hanada K
    J Biol Chem; 2014 Jul; 289(30):20802-12. PubMed ID: 24923447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential roles for ubiquitin and the proteasome during ribosome biogenesis.
    Stavreva DA; Kawasaki M; Dundr M; Koberna K; Müller WG; Tsujimura-Takahashi T; Komatsu W; Hayano T; Isobe T; Raska I; Misteli T; Takahashi N; McNally JG
    Mol Cell Biol; 2006 Jul; 26(13):5131-45. PubMed ID: 16782897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient apoptosis and necrosis induction by proteasome inhibitor: bortezomib in the DLD-1 human colon cancer cell line.
    Krętowski R; Stypułkowska A; Cechowska-Pasko M
    Mol Cell Biochem; 2015 Jan; 398(1-2):165-73. PubMed ID: 25292312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.